TannerFCBoulangerCMLuscherTF. Endothelium-derived nitric oxide, endothelin, and platelet vessel wall interaction: alterations in hypercholesterolemia and atherosclerosis. Semin Thromb Hemost1993; 19: 167–75.
2.
SkopBPFinkelsteinJMarethTRMagoonMBrownTM. The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease: a case report and review. Am J Emerg Med1994; 12: 642–4.
3.
LowensteinCJDinermanJLSnyderSH. Nitric oxide: a physiologic messenger. Ann Intern Med1994; 120: 227–37.
4.
SkopBPBrownTM. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics (in press).
5.
FaraciFMBrianJE. Nitric oxide and the cerebral circulation. Stroke1994; 25: 692–703.
6.
SternbachH. The serotonin syndrome. Am J Psychiatry1991; 148: 705–13.
7.
NierenbergDWSemprebonM. The central nervous system serotonin syndrome. Clin Pharmacol Ther1993; 53: 84–8.
8.
McFaddenEPClarkJGDaviesGJKaskiJCHaiderAWMaseriA. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med1991; 324: 648–54.
9.
GolinoPPiscioneFWillersonJTCappelli-BigazziMFocaccioAVillariBDivergent effects of serotonin on coronary artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med1991; 324: 641–8.
10.
SpierSAFronteraMA. Unexpected deaths in depressed medical inpatients treated with fluoxetine. J Clin Psychiatry1991; 52: 377–82.
